Agrin released by motoneurons induces and/or maintains acetylcholine receptor (AChR) clustering and other aspects of postsynaptic differentiation at the vertebrate neuromuscular junction. Agrin acts by binding and activating a receptor complex containing LDL receptor protein 4 (Lrp4) and muscle-specific kinase (MuSK). Two critical downstream components of this signaling cascade, Dox-7 and rapsyn, have been identified. However, additional intracellular essential elements remain unknown. Prior observations by others and us suggested antagonistic interactions between agrin and neuregulin-1 (Nrg-1) signaling in cultured myotubes and developing muscle fibers in vivo. A hallmark of Nrg-1 signaling in skeletal muscle cells is the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2). ERK1/2 are also activated in most cells by phorbol 12-myristate 13-acetate, a classical inhibitor of agrin-induced AChR clustering in myotubes. Here, it was investigated whether agrin activates ERK1/2 directly and whether such activation modulates agrin-induced AChR clustering. Agrin induced a rapid but transient activation of ERK1/2 in myotubes that was Lrp4/MuSK-dependent. However, blocking this ERK1/2 activation did not prevent but potentiated AChR clustering induced by agrin. ERK1/2 activation was dispensable for Nrg-1-mediated inhibition of the AChR clustering activity of agrin, but was indispensable for such activity by phorbol 12-myristate 13-acetate. Together, these results suggest agrin-induced activation of ERK1/2 is a negative modulator of agrin signaling in skeletal muscle cells.For more than a decade, three proteins have stood out as the essential signaling partners in vertebrate neuromuscular junction (NMJ) 2 synaptogenesis. Agrin, a proteoglycan released by motoneurons that induces and/or maintains acetylcholine receptor (AChR) clustering and other aspects of postsynaptic differentiation (1). MuSK, a receptor tyrosine kinase activated by agrin (2, 3); and rapsyn, an intracellular peripheral membrane protein that binds to AChRs (4, 5). Recently, two additional key components of this signaling pathway have been discovered: Lpr4, a LDL-like receptor protein that binds agrin and associates with MuSK (6, 7); and Dok-7 (8), a phosphotyrosinebinding protein that binds to activated MuSK. In the absence of any of these proteins, neuromuscular synapses simply fail to form in vivo (8 -12). Despite this impressive progress, how agrin-induced MuSK activation leads to AChR clustering remains elusive as additional critical intracellular components of the core pathway are yet to be identified.Previously, Trinidad and Cohen (13) showed that in cultured myotubes agrin-induced AChR clustering was inhibited by cotreatment with Nrg-1. We showed that agrin failed to cluster AChRs in cultured myotubes expressing a constitutively active neuregulin receptor ErbB2 (14). Importantly, when expressed in developing muscle fibers in vivo, constitutively active ErbB2 led to synaptic loss resembling the neuromuscular phenotype in mice defici...